| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07393425 | Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast Cancer | HER2 + Breast Cancer | Recruiting |
| NCT07317778 | Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2… | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05074290 | Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients | Breast Cancer | Recruiting |